- Home
- ABOS vs OGI Comparison
ABOS vs OGI Comparison
Compare ABOS & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABOS | OGI |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.0M | 189.5M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ABOS | OGI |
|---|---|---|
| Price | $2.52 | $1.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 292.3K | ★ 837.0K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.10 |
| Revenue Next Year | N/A | $13.92 |
| P/E Ratio | ★ N/A | $13.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $1.04 |
| 52 Week High | $3.60 | $2.24 |
Technical Indicators
Market Signals| Indicator | ABOS | OGI |
|---|---|---|
| Relative Strength Index (RSI) | 51.64 | 35.89 |
| Support Level | $2.24 | N/A |
| Resistance Level | $2.77 | $1.71 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 66.41 | 20.51 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.